Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 3,452 shares at $44.62 ($154K) on 2019-04-09, disclosed to the SEC on 2019-04-11.
Open-market sale of $154k XLRN by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XLRN | SELL | 2017-09-14 | $176K | — | Filing → |
| XLRN | SELL | 2017-08-09 | $463K | — | Filing → |
| XLRN | SELL | 2016-10-11 | $1.8M | — | Filing → |